American College of Chest Physicians has published new expert panel guidance around the use of low-dose CT.
There is new evidence-based guidance for the use of low-dose CT (LDCT) for lung cancer screening from the American College of Chest Physicians.
In an article published July 13 in CHEST, an expert panel from the College released 16 clinical recommendations based on a review of 75 studies. The new guidelines focus on the benefits, harms, and implementation of LDCT.
“The goal of these guidelines is to assist stakeholders with the development of high-quality screening programs and arm clinical providers with the information necessary to engage at-risk individuals in order to increase the number of screenings,” said lead author Peter Mazzone, M.D., MPH, FCCP. “Outlined in the recommendations is who should be screened and what that screening process should look like from the clinical side. For an individual patient, these guidelines highlight the importance of education to foster informed, value-based decisions about whether to be screened.”
Here is a summary of the 16 recommendations:
As a supplement to these published recommendations, CHEST and Thomas Jefferson University are offering a course dedicated to helping patients decide whether to undergo screening.
For more coverage based on industry expert insights and research, subscribe to the Diagnostic Imaging e-Newsletter here.
Photon-Counting Computed Tomography: Eleven Takeaways from a New Literature Review
May 27th 2025In a review of 155 studies, researchers examined the capabilities of photon-counting computed tomography (PCCT) for enhanced accuracy, tissue characterization, artifact reduction and reduced radiation dosing across thoracic, abdominal, and cardiothoracic imaging applications.
Can AI Predict Future Lung Cancer Risk from a Single CT Scan?
May 19th 2025In never-smokers, deep learning assessment of single baseline low-dose computed tomography (CT) scans demonstrated a 79 percent AUC for predicting lung cancer up to six years later, according to new research presented today at the American Thoracic Society (ATS) 2025 International Conference.
Can Emerging AI Software Offer Detection of CAD on CCTA on Par with Radiologists?
May 14th 2025In a study involving over 1,000 patients who had coronary computed tomography angiography (CCTA) exams, AI software demonstrated a 90 percent AUC for assessments of cases > CAD-RADS 3 and 4A and had a 98 percent NPV for obstructive coronary artery disease.